检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:栾海虹[1] 王士雷[2] 王世端[2] 江岩[2] 袁莉[2] 刘英志[2]
机构地区:[1]青岛大学医学院 [2]青岛大学医学院附属医院麻醉科
出 处:《中国临床药理学与治疗学》2007年第12期1424-1427,共4页Chinese Journal of Clinical Pharmacology and Therapeutics
基 金:山东省科技攻关计划赞助(2006GG3202004)
摘 要:目的:探讨地塞米松对体外循环下心脏瓣膜置换术患者血S-100β和神经元特异性烯醇化酶(NSE)的影响及其机制。方法:择期体外循环下心脏瓣膜置换术病人30例,年龄31~63岁,体重46~76 kg,ASAⅡ或Ⅲ级,随机分为地塞米松组和对照组。地塞米松组于手术开始前1 h静注地塞米松0.5 mg/kg,对照组静注等量生理盐水。在静注地塞米松前(T_1)、体外循环开始(转机)即刻(T_2)、体外循环结束时(T_3)、手术结束时(T_4)、术后24 h(T_5)、术后48 h(T_6)采集静脉血(T_1取自外周静脉,T_2~T_6取自颈内静脉置管),采用ELISA法测定TNF-α、IL-1β及脑损伤标志物S-100β蛋白和NSE的浓度。结果:两组病人IL-1β、TNF-α浓度在T_2~T_5均高于T_1(P<0.05),且地塞米松组低于对照组(P<0.05),T_6恢复至T_1水平。两组病人NSE浓度在T_3~T_6时明显高于T_1~T_2(P<0.05),且T_3~T_5时地塞米松低于对照组(P<0.05)。两组病人S- 100β蛋白浓度在T_3~T_5时高于T_1~T_2(P<0.05),T_6时基本恢复至T_1水平,且在T_3~T_4时地塞米松低于对照组(P<0.05)。结论:地塞米松能降低心脏瓣膜置换术病人血S-100β和NSE的水平,其脑保护机制与减少促炎细胞因子释放有关。AIM: To observe the effects of dexamethasone (DXM) on blood S-100β and Neuron Specific Enolase(NSE) levels of cardiac valve replacement patients undergoing cardiopulmonary bypass ( CPB ). METHODS: 30 patients, who were 31 - 63 years old, weighted 46 - 76 kg, ASA Ⅱ - Ⅲ, were randomized to received 0.5 mg/kg dexamethasone ( dexamethasone group) or placebo( control group) 60 minutes before operation. The plasma levels of TNF-α, IL-1β, S-100β and NSE were measured at the following times: before the dexamethasone or placebo were administered( T1 ), before starting CPB( T2 ), the end of CPB( T3 ), immediately after operation(T4), 24 h after skin closure(T5 ) and 48 h after skin closure( T6 ). RESULTS: Both the plasma concentrations of TNF-α, IL-1β were upregulated after T2. S-100β and NSE were upregulated after T3 ( P 〈 0.05) and almostly resume to normal level at T6. The plasma concentrationS of TNF-α, IL-1β, S-100β and NSE in dexamethasone group were lower than those in placebo group (P 〈 0.05 ). CONCLUSION: Dexamethasone may decrease the blood S-100β and NSE levels after cardiopulmonary bypass by inhibitting the release of proinflammatory cytokine.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28